Fennec Pharmaceuticals (TSX:FRX) Price-to-Tangible-Book : (As of May. 01, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Fennec Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-05-01), Fennec Pharmaceuticals's share price is C$12.58. Fennec Pharmaceuticals's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was C$-0.58. Hence, Fennec Pharmaceuticals's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Fennec Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Fennec Pharmaceuticals's highest Price to Tangible Book Ratio was 45.22. The lowest was 5.94. And the median was 7.35.

TSX:FRX's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.69
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Fennec Pharmaceuticals's share price is C$12.58. Fennec Pharmaceuticals's Book Value per Sharefor the quarter that ended in Dec. 2023 was C$-0.58. Hence, Fennec Pharmaceuticals's P/B Ratio of today is .

Fennec Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for Fennec Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fennec Pharmaceuticals Price-to-Tangible-Book Chart

Fennec Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

10.75

6.35

7.22

Fennec Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Fennec Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, Fennec Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fennec Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fennec Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Fennec Pharmaceuticals's Price-to-Tangible-Book falls into.

Fennec Pharmaceuticals Price-to-Tangible-Book Calculation

Fennec Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	12.58	/	-0.577
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Fennec Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Fennec Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Fennec Pharmaceuticals (TSX:FRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fennec Pharmaceuticals Inc (TSX:FRX) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

FENC:USA RV41:Germany

Address

68 TW Alexander Drive, PO Box 13628, Research Triangle Park, NC, USA, 27709

Website

https://www.fennecpharma.com

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. The company principally operates in the United States.